InsidersTradesSigma
Follow the Sudeep Pharma share price and the full directors' dealings record of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Market capitalisation: €130.2bn. The latest transaction was reported on 11 August 2026 (Disposal). Among the most active insiders: Nuvama Crossover Opportunities Fund Series III. The full history is accessible without an account.
Analysts rate Sudeep Pharma Underperform (bearish), based on 2 analysts. Average price target: ₹777.50.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Sudeep Pharma is a company operating in the XBOM market, specializing in the pharmaceutical sector. It focuses on the research, development, and marketing of pharmaceutical products.